Drug name - Actoplus Met

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9101660 TAKEDA PHARMS USA Solid preparation Jan, 2027

(4 years from now)

US9320714 TAKEDA PHARMS USA Tablet Feb, 2029

(6 years from now)

More Information on Dosage
Strength Dosage Availability
500MG;EQ 15MG BASE TABLET;ORAL Prescription
850MG;EQ 15MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.